Amgen Inc.

April 1, 2019 A lawsuit focuses on three pharmaceutical companies’ alleged conspiracy to maintain a monopoly over the market for arthritis treatment Humira.

February 22, 2019 Amgen Inc., Teva Pharmaceuticals USA, Inc. and three Teva subsidiaries have been named in a proposed class action in which they’re accused of entering into an unlawful, anticompetitive agreement that led consumers to pay inflated prices for Sensipar.